IL-1-driven stromal–neutrophil interactions define a subset of patients with inflammatory bowel disease that does not respond to therapiesMatthias Friedrich, Kevin Wei, Gerald F. Watts et al.|Nature Medicine|2021Cited by 289
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel diseaseTom Thomas, Christopher D. Buckley, Matthias Friedrich et al.|Nature Immunology|2024Cited by 83
MHC class II antigen presentation by intestinal epithelial cells fine-tunes bacteria-reactive CD4 T-cell responsesCornelia Heuberger, Kevin J. Maloy, Alina Janney et al.|Mucosal Immunology|2023Cited by 44
A conserved population of MHC II-restricted, innate-like, commensal-reactive T cells in the gut of humans and miceCarl-Philipp Hackstein, Emily Thornton, Dana Costigan et al.|Nature Communications|2022Cited by 20
MHC class II antigen presentation by intestinal epithelial cells fine-tunes bacteria-reactive CD4 T cell responsesCornelia Heuberger, Kevin J. Maloy, Alina Janney et al.|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 3